Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
1021/cb2002413
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Christiansen E
the biologically active form of MLN9708
Ciacciarelli M
SMI-4a - CAS# 438190-29-5 0256 1021/cb2002413SMI 4a, CAS No. 438190 29 5, is a potent and selective Pim protein kinase inhibitor, which blocks the growth of precursor T cell lymphoblastic leukemia lymphoma. SMI 4a was found to induce phosphorylation of extracellular signal related kinase1 2 (ERK1 2), and the combination of SMI 4a and a mitogen activated protein kinase kinase 1 2 (MEK1 2) inhibitor was highly synergistic in killing pre T LBL cells. SMI 4a may be developed as a therapeutic
US$ 672.00
US$ 1482.00
US$ 604.50
US$ 672.00
US$ 1847.00
US$ 287.00
US$ 641.50
US$ 604.50
US$ 2512.00
US$ 489.50
US$ 767.50
US$ 468.50
US$ 1084.00
US$ 3138.50
US$ 767.50
US$ 215.00
US$ 523.50